Cargando…
Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction
INTRODUCTION: Tuberculosis (TB) treatment requires the combination of multiple anti-TB drugs during 6 months or more depending on strain drug susceptibility profile. Optimizing the monitoring of anti-TB therapy efficacy is required to provide adequate care and prevent drug resistance emergence. More...
Autores principales: | Bahuaud, Olivier, Genestet, Charlotte, Hoffmann, Jonathan, Dumitrescu, Oana, Ader, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515406/ https://www.ncbi.nlm.nih.gov/pubmed/36186786 http://dx.doi.org/10.3389/fmed.2022.998972 |
Ejemplares similares
-
Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion
por: Genestet, Charlotte, et al.
Publicado: (2021) -
Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017–2018
por: Genestet, Charlotte, et al.
Publicado: (2019) -
The MTB/MDR ELITe MGB(®) Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French Center
por: Hodille, Elisabeth, et al.
Publicado: (2021) -
Assessment of closely related Mycobacterium tuberculosis variants with different transmission success and in vitro infection dynamics
por: Abascal, Estefanía, et al.
Publicado: (2021) -
MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis
por: Flandrois, Jean-Pierre, et al.
Publicado: (2014)